Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ophthotech Corp (NASDAQ:OPHT)

2.45
Delayed Data
As of 3:59pm ET
 -0.02 / -0.81%
Today’s Change
2.24
Today|||52-Week Range
40.34
-49.28%
Year-to-Date
No recent news for Ophthotech Corp.

Today’s Trading

Previous close2.47
Today’s open2.45
Day’s range2.36 - 2.49
Volume405,997
Average volume (3 months)579,346
Market cap$88.8M
Dividend yield--
Data as of 3:59pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)-78.10%
Earnings growth (this year)+95.62%
Earnings growth (next 5 years)--
Revenue growth (last year)-1.16%
P/E ratioNM
Price/Sales3.37
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ORMPOramed Pharmaceutica...-0.20-1.85%
BLRXBioLine RX Ltd-0.01-0.88%
GLMDGalmed Pharmaceutica...-0.25-3.21%
RGLSRegulus Therapeutics...-0.07-5.30%
Data as of 3:59pm ET, 10/19/2017

Financials

Next reporting dateNovember 15, 2017
EPS forecast (this quarter)$2.33
Annual revenue (last year)$50.9M
Annual profit (last year)-$193.4M
Net profit margin-379.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Glenn P. Sblendorio
Chief Operating Officer &
Senior Vice President
Keith Westby
Corporate headquarters
New York, New York

Forecasts